Evidence map›Paper›PMID 15995205›Full record

ArticleJournal of bacteriology2005

Rapid detection of colicin E9-induced DNA damage using Escherichia coli cells carrying SOS promoter-lux fusions.

Mireille Vankemmelbeke, Bryan Healy, Geoffrey R Moore, Colin Kleanthous, Christopher N Penfold, Richard James

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Journal of bacteriology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. The role of SOS boxes in enteric bacteriocin regulation.Microbiology (Reading, England) · 2008
    Article
  12. Article
  13. Article
  14. Colicin biology.Microbiology and molecular biology reviews : MMBR · 2007
    Review
  15. Article
  16. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Mireille VankemmelbekeCentre for Biomolecular Sciences, University of Nottingham, University Park, UK.
Bryan Healy
Geoffrey R Moore
Colin Kleanthous
Christopher N Penfold
Richard James
University of Nottingham · GBUniversity of East Anglia · GBUniversity of York · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ColE9 is a plasmid-encoded protein antibiotic produced by Escherichia coli and closely related species that kills E. coli cells expressing the BtuB receptor. The 15-kDa cytotoxic DNase domain of colicin E9 preferentially nicks double-stranded DNA at thymine bases and shares a common active-site structural motif with a variety of other nucleases, including the H-N-H homing endonucleases and the apoptotic CAD proteins of eukaryotes. Studies of the mechanism by which the DNase domain of ColE9 reaches the cytoplasm of E. coli cells are limited by the lack of a rapid, sensitive assay for the DNA damage that results. Here, we report the development of an SOS promoter-lux fusion reporter system for monitoring DNA damage in colicin-treated cells and illustrate the value of this reporter system in experiments that probe the mechanism and time required for the DNase domain of colicin E9 to reach the cytoplasm.

Indexed as

DNA DamageColicinsDithiothreitolDNA, BacterialEscherichia coliEscherichia coli ProteinsGenes, ReporterKineticsLuminescent MeasurementsPlasmidsPromoter Regions, GeneticRecombinant Fusion ProteinsSOS Response, GeneticsColicinsDithiothreitolDNA, BacterialEscherichia coli ProteinsimmE9 protein, E coliRecombinant Fusion Proteins

Identifiers

PMID15995205
PMCPMC1169509
OpenAlexW2100584256

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.